Europe - Frankfurt Stock Exchange - FRA:DUL - US02043Q1076 - Common Stock
Overall DUL gets a technical rating of 3 out of 10. In the last year, DUL was among the worst performers in the market. Also the short term picture is negative, the medium term is unclear at the moment.
The technical rating of DUL is bad and it also does not present a quality setup at the moment. Prices have been extended to the downside lately. For a nice entry it is better to wait for a consolidation.
307.49
We found 1 important resistance area.
The Technical Rating and Setup analysis above combine different indicators and trends in different timeframes. Individual signals from indicators may give more contradictive signals and should always be interpreted in the more global context.
| Indicator | Value | Signal | Comment |
|---|---|---|---|
| ChartMill Long Term Trend Indicator | UP | POSITIVE | The long term trend for DUL.DE is up. |
| ChartMill Short Term Trend Indicator | UP | POSITIVE | The short term trend for DUL.DE is up. |
| ChartMill Relative Strength | 0 | NEGATIVE | DUL.DE has a low relative strength, it was outperformed by 100% off all stocks on the market. |
| Relative Strength Index/RSI (14) | 28.69 | OVERSOLD | The low RSI value suggests DUL.DE may be oversold. |
| Moving Average Convergence Divergence/MACD (12, 26, 9) | -10.44 | NEGATIVE | The MACD value suggests DUL.DE has a negative trend. |
| Stochastics (14,3) | 1.63 | OVERSOLD | The low Stochastics value suggests DUL.DE may be oversold. |
| Average Directional Index/ADX (14) | 31.83 | POSITIVE | The high ADX value value for DUL.DE suggests a strong trend. |
FRA:DUL (1/16/2026, 7:00:00 PM)
310.6
-3.2 (-1.02%)
ChartMill assigns a technical rating of 3 / 10 to DUL.DE.
The current trend direction for ALNYLAM PHARMACEUTICALS INC (DUL.DE) is Bullish.
ALNYLAM PHARMACEUTICALS INC (DUL.DE) has an RSI value of 28.6918. This indicates that the stock is currently oversold.
The short term momentum for ALNYLAM PHARMACEUTICALS INC (DUL.DE) is positive.
The buy/sell signal for ALNYLAM PHARMACEUTICALS INC (DUL.DE) is buy as both the short term and long term trends are positive.